drugset
drugset / Trial / NCT04181437

Pharmacokinetic Interaction and Safety Between NVP-1203-R1 and NVP-1203-R2

NCT04181437 ↗

Phase 1 Completed 40 enrolled NVP Healthcare
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare the pharmacokinetics and safety between NVP-1203-R1 and NVP-1203-R2

Timeline

Start
2020-05-01
Primary completion
2020-05-17
Completion
2020-05-29

Drugs

EvaluationDrugModalityDoseRoute
Subject NVP-1203-R1 Unknown — Oral
Subject NVP-1203-R2 Unknown — Oral

Indications

No indication recorded.